Investment Analysts’ Price Target Changes for September 4th (AEM, BTG, CHPT, CS, DSGX, FIVE, FM, HBM, IAG, IMAX)

Investment Analysts’ price target changes for Friday, September 4th:

Agnico Eagle Mines (NYSE:AEM) (TSE:AEM) had its target price cut by Raymond James Financial, Inc. from $230.00 to $225.00. The firm currently has an outperform rating on the stock.

B2Gold (NYSEAMERICAN:BTG) (TSE:BTO) had its target price raised by Raymond James Financial, Inc. from $7.25 to $7.50. They currently have an outperform rating on the stock.

ChargePoint (NYSE:CHPT) had its price target raised by B. Riley Financial, Inc. from $6.00 to $8.00. B. Riley Financial, Inc. currently has a neutral rating on the stock.

Capstone Copper (TSE:CS) had its price target increased by Raymond James Financial, Inc. from C$18.50 to C$19.00. They currently have an outperform rating on the stock.

The Descartes Systems Group (NASDAQ:DSGX) (TSE:DSG) was given a $125.00 price target by analysts at Royal Bank Of Canada. The firm currently has an outperform rating on the stock.

Five Below (NASDAQ:FIVE) had its price target raised by The Goldman Sachs Group, Inc. from $257.00 to $306.00. The firm currently has a buy rating on the stock.

First Quantum Minerals (TSE:FM) had its price target raised by Raymond James Financial, Inc. from C$45.00 to C$47.00. Raymond James Financial, Inc. currently has a market perform rating on the stock.

Hudbay Minerals (TSE:HBM) (NYSE:HBM) had its target price raised by Raymond James Financial, Inc. from C$41.00 to C$42.00. The firm currently has an outperform rating on the stock.

Iamgold (NYSE:IAG) (TSE:IMG) had its target price boosted by Raymond James Financial, Inc. from $20.00 to $21.00. Raymond James Financial, Inc. currently has a market perform rating on the stock.

IMAX (NYSE:IMAX) had its price target boosted by The Goldman Sachs Group, Inc. from $42.00 to $50.00. The firm currently has a neutral rating on the stock.

Samsara (NYSE:IOT) had its price target increased by BNP Paribas Exane from $40.00 to $55.00. The firm currently has an outperform rating on the stock.

Keyera (TSE:KEY) had its target price cut by TD from C$70.00 to C$67.00. TD currently has a buy rating on the stock.

Keyera (TSE:KEY) had its price target boosted by Citigroup Inc. from C$102.00 to C$106.00. The firm currently has a buy rating on the stock.

Keyera (TSE:KEY) had its target price boosted by Stifel Nicolaus from C$85.00 to C$90.00. They currently have a hold rating on the stock.

Keyera (TSE:KEY) had its price target raised by Desjardins from C$103.00 to C$112.00. The firm currently has a buy rating on the stock.

Keyera (TSE:KEY) had its target price raised by Scotia from C$88.00 to C$92.00. The firm currently has a sector perform rating on the stock.

Keyera (TSE:KEY) had its price target lowered by BMO Capital Markets from C$65.00 to C$64.00. BMO Capital Markets currently has an outperform rating on the stock.

lululemon athletica (NASDAQ:LULU) had its price target lowered by BNP Paribas Exane from $88.00 to $44.00. The firm currently has an underperform rating on the stock.

lululemon athletica (NASDAQ:LULU) had its target price cut by Barclays PLC from $113.00 to $95.00. Barclays PLC currently has an equal weight rating on the stock.

lululemon athletica (NASDAQ:LULU) had its price target trimmed by The Goldman Sachs Group, Inc. from $111.00 to $95.00. They currently have a neutral rating on the stock.

Ultragenyx Pharmaceutical (NASDAQ:RARE) had its target price lowered by The Goldman Sachs Group, Inc. from $28.00 to $19.00. The Goldman Sachs Group, Inc. currently has a neutral rating on the stock.

Teva Pharmaceutical Industries (NYSE:TEVA) had its price target boosted by UBS Group AG from $42.00 to $48.00. They currently have a buy rating on the stock.